COVID-19 variants, vaccines and the value of rapid testing
As variants evolve, vaccination gaps persist, and mask measures relax, diagnostic testing remains a cornerstone in the global fight against COVID-19. This multi-disciplinary educational program will highlight variant surveillance and testing protocols from Europe to the U.S. and explore the imperative of COVID-19 testing protocols to optimize patient care and public health readiness with an uncertain upcoming influenza season.
- Gain expert insight on virus surveillance from the Abbott Virus Hunters, an expert team that is identifying, cataloging, and tracking evolving COVID-19 strains;
- Learn the latest on the critical role of routine rapid testing in reducing the spread of SARS-CoV-2 and tracking highly contagious variants;
- Review practical considerations for testing protocols and use cases in the selection of rapid antigen and molecular testing;
- Discover ways to manage simultaneous diagnostic demands of COVID-19 and Influenza
NORMAN MOORE, PhD
Introduction and Presentations
JOHN R. HACKETT JR, PhD
Meeting the challenge of viral diversity: The Abbott global viral surveillance program
SHELDON CAMPBELL, MD, PhD
Direct test for virus: antigen or molecular?
MOHAMMAD RAZA, MBBS, BSC, FRCP, FRCPath (Virology)
To NAAT or not to NAAT?
Les points de vue et opinions présentés n'engagent que les auteurs. Le contenu de ce webcast est destiné à des fins d'information / éducatives uniquement.
© 2023 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model. Products available in select markets only. COL-00000